Advertisement

Latest News

AAD 2026: 6 Psoriasis Trials to Know

18 minutes ago

This review of new data on psoriasis treatments from AAD 2026 highlights several key trials.

5 Nephrology Headlines You Missed in March 2026

2 hours ago

Catch up on the guideline updates, trial news, and featured content from March 2026.

Diabetes Dialogue: 2026 AACE Guidelines for Type 2 Diabetes

3 hours ago

This episode discusses the recently released algorithm for T2D from the American Association of Clinical Endocrinology.

Q2 2026 Preview: 6 FDA Decisions to Watch

3 hours ago

Check out 6 FDA decisions to watch in Q2 2026, listed chronologically by expected decision date.

Tonlamarsen Lowers Angiotensinogen, Mixed Results for Blood Pressure, With Luke Laffin, MD

3 hours ago

Laffin discusses results from the Kardinal study, which investigated a single dose of tonlamarsen followed by placebo against monthly tonlamarsen treatment in hypertension.

Advertisement
Advertisement